The goal of the study is to compare the survival of bladder-intact patients receiving a combination of radiation therapy and pembrolizumab or radiation therapy and chemotherapy.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Bladder - Urothelial
Webform